The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Schwabe Stefan K.f. since year 2005.
The trader's CIK number is 1557657.
At the time of the last reporting, Schwabe Stefan K.f. was the Executive Vice President R&D of Supernus Pharmaceuticals Inc .
(stock ticker symbol SUPN).
See this page for all insider trading activities at Supernus Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-06-18||SUPN||Supernus Pharmaceuticals Inc||Sale||60,000||54.39||3,263,340|
|2018-06-18||SUPN||Supernus Pharmaceuticals Inc||Option Ex||60,000||8.57||514,200|
|2017-09-07||SUPN||Supernus Pharmaceuticals Inc||Sale||95,000||46.59||4,425,575|
|2017-09-07||SUPN||Supernus Pharmaceuticals Inc||Option Ex||95,000||12.92||1,227,400|
|2015-07-28||SUPN||Supernus Pharmaceuticals Inc||Sale||2,350||21.20||49,831|
|2015-07-13||SUPN||Supernus Pharmaceuticals Inc||Sale||1,950||19.23||37,498|
|2015-06-12||SUPN||Supernus Pharmaceuticals Inc||Sale||2,051||18.27||37,471|
|2015-06-11||SUPN||Supernus Pharmaceuticals Inc||Sale||3,631||16.38||59,464|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schwabe Stefan K.f. (Executive Vice President R&D of Supernus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.